Literature DB >> 566721

Primary monolayer cultures of postnatal rat liver cells with extended differentiated functions.

D Acosta, D C Anuforo, R V Smith.   

Abstract

Monolayers of liver cells cultured from postnatal rats were grown in two types of media. One set of cultures was grown in selective medium which contained ornithine but was deficient in arginine; the other set was grown in nonselective medium which contained arginine but no ornithine. The cultures that were grown in the nonselective medium contained primarily a mixture of two cell types found in the liver: parenchymal hepatocytes and fibroblast-like cells. The fibroblast cells tended to overgrow the hepatocytes after several days in culture. In contrast, fibroblast overgrowth was inhibited in cultures grown in the selective, arginine-deficient medium, thereby resulting in relatively pure cultures of functional parenchymal hepatocytes. Comparative studies of sulfobromophthalein (BSP) uptake showed that the cultures grown in selective medium continued to be active much longer than the cultures grown in the nonselective medium. Pyruvate kinase assays revealed that the cultures grown in selective medium contained primarily the L-isoenzyme type which is characteristic of parenchymal hepatocytes. Cultures grown in nonselective medium contained a mixture of L- and M-isoenzymes which is indicative of nonparenchymal liver cells. The reported results indicate that selective, arginine-deficient medium permits primarily the growth of parenchymal hepatocytes found in neonatal rat liver.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 566721     DOI: 10.1007/bf02616104

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  27 in total

1.  Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations.

Authors:  G Michalopoulos; H C Pitot
Journal:  Exp Cell Res       Date:  1975-08       Impact factor: 3.905

2.  Studies on the persistence of differentiated functions in rat hepatocytes set into primary tissue cultures. Specific binding of 3H-bilirubin after eight days of staying in vitro.

Authors:  U Armato; E Draghi; P G Andreis
Journal:  Cell Differ       Date:  1975-06

3.  Tests for hepatic dysfunction of mice.

Authors:  J CASALS; P K OLITSKY
Journal:  Proc Soc Exp Biol Med       Date:  1946-11

4.  Fructose 1,6-diphosphate, a reactivator of Cu++-inhibited pyruvate kinase from liver.

Authors:  S Passeron; L Jiménez de Asua; H Carminatti
Journal:  Biochem Biophys Res Commun       Date:  1967-04-07       Impact factor: 3.575

5.  Release of specific hepatic enzymes into medium in primary liver cell cultures.

Authors:  C Guguen-Guillouzo; M F Szajnert; F Schapira
Journal:  Biomedicine       Date:  1976-07

6.  The isolation of hormone-sensitive rat hepatocytes by a modified enzymatic technique.

Authors:  R N Zahlten; F W Stratman
Journal:  Arch Biochem Biophys       Date:  1974-08       Impact factor: 4.013

7.  Isolation and long-term cell culture of epithelial-like cells from rat liver.

Authors:  G M Williams; E K Weisburger; J H Weisburger
Journal:  Exp Cell Res       Date:  1971-11       Impact factor: 3.905

8.  Distribution of L- and M-type pyruvate kinase between parenchymal and Kupffer cells of rat liver.

Authors:  T J van Berkel; J F Koster; W C Hülsmann
Journal:  Biochim Biophys Acta       Date:  1972-08-28

9.  Studies on primary cultures of differentiated fetal liver cells.

Authors:  H L Leffert; D Paul
Journal:  J Cell Biol       Date:  1972-03       Impact factor: 10.539

10.  Biogenesis of endoplasmic reticulum membranes. I. Structural and chemical differentiation in developing rat hepatocyte.

Authors:  G Dallner; P Siekevitz; G E Palade
Journal:  J Cell Biol       Date:  1966-07       Impact factor: 10.539

View more
  14 in total

1.  Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP treatment.

Authors:  J P Pégorier; M V Garcia-Garcia; C Prip-Buus; P H Duée; C Kohl; J Girard
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

2.  Cell culture systems and in vitro toxicity testing. Technical report no. 4 of the Johns Hopkins Center for Alternatives to Animal Testing (CAAT): technical workshop of June 13-15, 1990.

Authors: 
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Regulation of glucose-6-phosphate dehydrogenase synthesis and mRNA abundance in cultured rat hepatocytes.

Authors:  P Manos; R Nakayama; D Holten
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  Normal and benign human prostatic epithelium in culture. I. Isolation.

Authors:  M M Webber
Journal:  In Vitro       Date:  1979-12

5.  Hepatotoxicity studies with primary cultures of rat liver cells.

Authors:  D C Anuforo; D Acosta; R V Smith
Journal:  In Vitro       Date:  1978-12

6.  Inhibition of fibroblast proliferation in a culture of human endometrial stromal cells using a medium containing D-valine.

Authors:  M Frauli; H Ludwig
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

7.  An in vitro approach to the study of target organ toxicity of drugs and chemicals.

Authors:  D Acosta; E M Sorensen; D C Anuforo; D B Mitchell; K Ramos; K S Santone; M A Smith
Journal:  In Vitro Cell Dev Biol       Date:  1985-09

8.  Stimulation of DNA synthesis in primary cultures of adult rat hepatocytes by rat platelet-associated substance(s).

Authors:  A J Strain; J A McGowan; N L Bucher
Journal:  In Vitro       Date:  1982-02

9.  Changes in some chromatin and cytoplasmic enzymes of perinatal rat hepatocytes during culture.

Authors:  C Guguen-Guillouzo; L Tichonicky; M F Szajnert; J Kruh
Journal:  In Vitro       Date:  1980-01

10.  Modulation of functional activities in cultured rat hepatocytes.

Authors:  C Guguen-Guillouzo; A Guillouzo
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.